GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » ContextVision AB (OSL:CONTX) » Definitions » EV-to-EBITDA

ContextVision AB (OSL:CONTX) EV-to-EBITDA : 8.20 (As of May. 11, 2024)


View and export this data going back to 1997. Start your Free Trial

What is ContextVision AB EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, ContextVision AB's enterprise value is kr411.5 Mil. ContextVision AB's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was kr50.2 Mil. Therefore, ContextVision AB's EV-to-EBITDA for today is 8.20.

The historical rank and industry rank for ContextVision AB's EV-to-EBITDA or its related term are showing as below:

OSL:CONTX' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.99   Med: 20.03   Max: 313.24
Current: 8.2

During the past 13 years, the highest EV-to-EBITDA of ContextVision AB was 313.24. The lowest was 6.99. And the median was 20.03.

OSL:CONTX's EV-to-EBITDA is ranked better than
72.94% of 462 companies
in the Healthcare Providers & Services industry
Industry Median: 13.065 vs OSL:CONTX: 8.20

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-11), ContextVision AB's stock price is kr6.00. ContextVision AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was kr0.418. Therefore, ContextVision AB's PE Ratio for today is 14.35.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


ContextVision AB EV-to-EBITDA Historical Data

The historical data trend for ContextVision AB's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ContextVision AB EV-to-EBITDA Chart

ContextVision AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.77 27.72 22.88 14.15 10.47

ContextVision AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.15 12.67 11.67 9.21 10.47

Competitive Comparison of ContextVision AB's EV-to-EBITDA

For the Health Information Services subindustry, ContextVision AB's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ContextVision AB's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, ContextVision AB's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where ContextVision AB's EV-to-EBITDA falls into.



ContextVision AB EV-to-EBITDA Calculation

ContextVision AB's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=411.535/50.173
=8.20

ContextVision AB's current Enterprise Value is kr411.5 Mil.
ContextVision AB's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr50.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ContextVision AB  (OSL:CONTX) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

ContextVision AB's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=6.00/0.418
=14.35

ContextVision AB's share price for today is kr6.00.
ContextVision AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.418.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


ContextVision AB EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of ContextVision AB's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


ContextVision AB (OSL:CONTX) Business Description

Traded in Other Exchanges
Address
Klara Norra Kyrkogata 31, Stockholm, SWE, SE-111 22
ContextVision AB is a Sweden-based medical technology company. It develops and sells image enhancement software for medical diagnosis and artificial intelligence. Its product portfolio includes image enhancement software for 2D/3D/4D (dimensional) ultrasound, magnetic resonance imaging (MRI), X-Ray, radiography, and mammography. its geographical segments are Asia, Europe, and America.

ContextVision AB (OSL:CONTX) Headlines

No Headlines